Loading…

The Edmonton Obesity Staging System Predicts Perioperative Complications and Procedure Choice in Obesity and Metabolic Surgery—a German Nationwide Register-Based Cohort Study (StuDoQ|MBE)

Objective To examine the relationship between Edmonton Obesity Staging System (EOSS) and perioperative complications as well as surgical procedure. Background The application of EOSS for the selection of patients with obesity is a more comprehensive measure of obesity-related diseases and a predicto...

Full description

Saved in:
Bibliographic Details
Published in:Obesity surgery 2019-12, Vol.29 (12), p.3791-3799
Main Authors: Chiappetta, Sonja, Stier, Christine, Weiner, Rudolf A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To examine the relationship between Edmonton Obesity Staging System (EOSS) and perioperative complications as well as surgical procedure. Background The application of EOSS for the selection of patients with obesity is a more comprehensive measure of obesity-related diseases and a predictor of mortality than body mass index (BMI). Methods This was a nationwide cohort study using prospectively inserted data from the German register for obesity and metabolic surgery StuDoQ|MBE. All patients undergoing sleeve gastrectomy (SG), Roux-en Y gastric bypass (RYGB), and one-anastomosis gastric bypass (OAGB) between February 2015 and July 2017 as a primary treatment for severe obesity were included. Data included gender, age, BMI, ASA score, EOSS, early postoperative complications next to the Clavien-Dindo grading system, readmission, and 30-day mortality. Results A total of 9437 patients were included. The mean BMI was 49.5 kg/m 2  ± 7.8 (range 35–103.5). The total postoperative complication rate was 5.3%, with the highest rate in EOSS 3 (7.8%) and 4 (6.8%). Thirty-day mortality was 0.2% with the highest mortality after SG in EOSS 3 (1.16%) and EOSS 4 (0.92%) ( p  = 0.0068). Crosstabs showed a prevalence of Clavien-Dindo III and IV complications of 3.4% (SG), 3.6% (RYGB), and 1.6% (OAGB) in EOSS 2 ( p  = 0.0032) and 3.5% (SG), 5.1% (RYGB), and 5.6% (OAGB) in EOSS 3. Conclusion The highest postoperative complications and mortality occurred in patients with EOSS ≥ 3. SG and OAGB could be the procedure of choice to reduce perioperative morbidity; nevertheless, it has to be in mind that in EOSS ≥ 3, SG has the highest mortality. Trial Registration ClinicalTrials.gov Identifier NCT03556059.
ISSN:0960-8923
1708-0428
DOI:10.1007/s11695-019-04015-y